Cargando…
Differential Stabilities of Mefloquine-Bound Human and Plasmodium falciparum Acyl-CoA-Binding Proteins
[Image: see text] Toxic effects of pharmacological drugs restrict their robust application against human diseases. Although used as a drug in the combinatorial therapy to treat malaria, the use of mefloquine is not highly recommended because of its adverse effects in humans. Mefloquine inhibits the...
Autores principales: | Kumar, Abhishek, Ghosh, Debasish Kumar, Ranjan, Akash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841788/ https://www.ncbi.nlm.nih.gov/pubmed/33521428 http://dx.doi.org/10.1021/acsomega.0c04582 |
Ejemplares similares
-
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
por: Gutman, Julie, et al.
Publicado: (2009) -
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2009) -
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023) -
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation
por: Bopp, Selina, et al.
Publicado: (2023) -
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India
por: Gargano, Nicola, et al.
Publicado: (2012)